HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells.

Abstract
Integrin activation is essential for the function of all blood cells, including platelets and leukocytes. The blood cell-specific FERM domain protein Kindlin-3 is required for the activation of the beta1 and beta3 integrins on platelets. Impaired activation of beta1, beta2 and beta3 integrins on platelets and leukocytes is the hallmark of a rare autosomal recessive leukocyte adhesion deficiency syndrome in humans called LAD-III, characterized by severe bleeding and impaired adhesion of leukocytes to inflamed endothelia. Here we show that Kindlin-3 also binds the beta2 integrin cytoplasmic domain and is essential for neutrophil binding and spreading on beta2 integrin-dependent ligands such as intercellular adhesion molecule-1 and the complement C3 activation product iC3b. Moreover, loss of Kindlin-3 expression abolished firm adhesion and arrest of neutrophils on activated endothelial cells in vitro and in vivo, whereas selectin-mediated rolling was unaffected. Thus, Kindlin-3 is essential to activate the beta1, beta2 and beta3 integrin classes, and loss of Kindlin-3 function is sufficient to cause a LAD-III-like phenotype in mice.
AuthorsMarkus Moser, Martina Bauer, Stephan Schmid, Raphael Ruppert, Sarah Schmidt, Michael Sixt, Hao-Ven Wang, Markus Sperandio, Reinhard Fässler
JournalNature medicine (Nat Med) Vol. 15 Issue 3 Pg. 300-5 (Mar 2009) ISSN: 1546-170X [Electronic] United States
PMID19234461 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CD18 Antigens
  • FERMT3 protein, human
  • Ligands
  • Membrane Proteins
  • Neoplasm Proteins
Topics
  • Animals
  • CD18 Antigens (physiology)
  • Cell Adhesion (physiology)
  • Endothelium, Vascular (cytology)
  • Humans
  • Leukocytes (cytology)
  • Ligands
  • Membrane Proteins (physiology)
  • Mice
  • Mice, Knockout
  • Neoplasm Proteins (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: